MODULATING POLYNUCLEOTIDES Russian patent published in 2021 - IPC C12N15/113 C12N15/85 

Abstract RU 2758488 C2

FIELD: biotechnology.

SUBSTANCE: modulating polynucleotide is described for reducing or inhibiting the gene expression in a cell, where the specified modulating polynucleotide contains: (a) a stem and a loop that form a “stem-loop” structure, (b) the first flanking region located in the direction 5' from the specified accompanying chain, where the specified first flanking region contains 5'-end flanking sequence and 5'-end spacer sequence, where the first flanking region contains a nucleotide sequence, which is at least 90% identical to SEQ ID NO:5, and (c) the second flanking region located in the direction 3' from the specified guide chain, where the specified second flanking region contains 3'-end spacer sequence and 3'-end flanking region, where the specified second flanking region contains a nucleotide sequence, which is at least 90% identical to SEQ ID NO:21.

EFFECT: invention expands the arsenal of means for the treatment of central nervous system (CNS) disease.

28 cl, 2 dwg, 4 tbl, 4 ex

Similar patents RU2758488C2

Title Year Author Number
METHODS AND COMPOSITIONS FOR TREATMENT OF HUNTINGTON'S CHOREA 2017
  • Sah, Dinah Wen-Yee
  • Hou, Jinzhao
  • Zhou, Pengcheng
  • Wang, Xin
  • Deckert, Jochen
  • Hossbach, Markus
RU2764587C2
RECOVERED NUCLEIC ACID WHICH CODES FVIII-BDD-BASED FUSION PROTEIN AND HETEROLOGOUS SIGNAL PEPTIDE, AND USE THEREOF 2022
  • Perepelkina Mariya Pavlovna
  • Vlasova Elena Veniaminovna
  • Fomina Anastasiia Vladimirovna
  • Gershovich Pavel Mikhailovich
  • Markova Vitaliia Aleksandrovna
  • Morozov Dmitry Valentinovich
RU2818229C2
VACCINE BASED ON AAV5 FOR INDUCTION OF SPECIFIC IMMUNITY TO SARS-CoV-2 VIRUS AND/OR PREVENTION OF CORONAVIRUS INFECTION CAUSED BY SARS-CoV-2 2020
  • Prokofev Aleksandr Vladimirovich
  • Gershovich Pavel Mikhajlovich
  • Strelkova Anna Nikolaevna
  • Spirina Natalya Aleksandrovna
  • Kondinskaya Diana Aleksandrovna
  • Yakovlev Pavel Andreevich
  • Morozov Dmitrij Valentinovich
RU2783313C1
VACCINE BASED ON AAV5 FOR THE INDUCTION OF SPECIFIC IMMUNITY TO THE SARS-CoV-2 VIRUS AND/OR THE PREVENTION OF CORONAVIRUS INFECTION CAUSED BY SARS-CoV-2 2021
  • Prokofyev Alexander Vladimirovich
  • Gershovich Pavel Mikhailovich
  • Strelkova Anna Nikolaevna
  • Spirina Natalia Aleksandrovna
  • Kondinskaia Diana Aleksandrovna
  • Iakovlev Pavel Andreevich
  • Morozov Dmitry Valentinovich
RU2761879C1
AAV5-BASED VACCINE FOR INDUCTION OF SPECIFIC IMMUNITY TO SARS-COV-2 VIRUS AND/OR PREVENTION OF CORONAVIRUS INFECTION CAUSED BY SARS-COV-2 2020
  • Gershovich Pavel Mikhailovich
  • Prokofyev Alexander Vladimirovich
  • Strelkova Anna Nikolaevna
  • Spirina Natalia Aleksandrovna
  • Shugaeva Tatiana Evgenievna
  • Iakovlev Pavel Andreevich
  • Morozov Dmitry Valentinovich
RU2760301C1
GENE THERAPY OF HYPOPHOSPHATEMIC DISEASES ASSOCIATED WITH FIBROBLAST GROWTH FACTOR 23 2020
  • Rontsitti, Dzhuzeppe
  • Zhoz, Luiza
  • Sharl, Severin
  • Mingotstsi, Frederiko
RU2815545C2
NEW LIVER TARGETING ADENO-ASSOCIATED VIRAL VECTORS 2019
  • Colosi, Peter Cameron
  • Ramirez, Silvia
RU2793735C2
MODULATION OF REP PROTEIN ACTIVITY WHEN PRODUCING CLOSED-END DNA (ceDNA) 2020
  • Kotin, Robert, Majkl
  • Ucher, Anna
  • Malakyan, Ara, Karl
RU2812850C2
ISOLATED MODIFIED VPI CAPSID PROTEIN OF ADENO-ASSOCIATED VIRUS OF SEROTYPE 9 (AAV9), CAPSID AND VECTOR BASED THEREON 2021
  • Strelkova Anna Nikolaevna
  • Shugaeva Tatyana Evgenevna
  • Gershovich Pavel Mikhajlovich
  • Yakovlev Pavel Andreevich
  • Morozov Dmitrij Valentinovich
RU2825667C2
VARIANTS OF ACID ALPHA-GLUCOSIDASE AND THEIR USE 2017
  • Mingozzi, Federico
  • Ronzitti, Giuseppe
RU2780410C2

RU 2 758 488 C2

Authors

Sah, Dinah Wen-Yee

Hou, Jinzhao

Nonnenmacher, Mathieu

Dates

2021-10-28Published

2017-05-18Filed